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Respiring mitochondria establish a proton gradient across the mitochondrial inner 
membrane (MIM) that is used to generate ATP. Protein-independent mitochondrial uncouplers 
collapse the proton gradient and disrupt ATP production by shuttling protons back across the 
MIM in a protonophoric cycle. Continued cycling relies on the formation of MIM-permeable 
anionic species that can return to the intermembrane space after deprotonation in the 
mitochondrial matrix. Previously described protonophores contain acidic groups that are part 
of delocalised π-systems that provide large surfaces for charge delocalisation and facilitate 
anion permeation across the MIM. Here we present a new class of protonophoric uncoupler 
based on aryl-urea substituted fatty acids in which an acidic group and a π-system are separated 
by a long alkyl chain. The aryl-urea group in these molecules acts as a synthetic anion receptor 
that forms intermolecular hydrogen bonds with the fatty acid carboxylate after deprotonation. 
Dispersal of the negative charge across the aryl-urea system produces lipophilic dimeric 
complexes that can permeate the MIM and facilitate repeated cycling. Substitution of the aryl-
urea group with lipophilic electron withdrawing groups is critical to complex lipophilicity and 
uncoupling activity. The aryl-urea substituted fatty acids represents the first biological example 
of mitochondrial uncoupling mediated by the interaction of a fatty acid and an anion receptor 






The mitochondrion supports cellular ATP production by oxidative phosphorylation 
(OxPhos, Figure 1). The organelle contains two distinct membranes: an outer membrane that 
is widely permeable to solutes and a relatively impermeable mitochondrial inner membrane 
(MIM) that encloses the mitochondrial matrix. Nutrients such as fatty acids and pyruvate are 
converted in the mitochondrial matrix to the high-energy electron carriers NADH and FADH2. 
These carriers donate electrons to the electron transport chain (ETC), a series of enzyme 
complexes embedded in the MIM that drive OxPhos. As electrons pass through the ETC 
complexes protons are pumped out of the matrix and into the inter-membrane space to produce 
an electrochemical gradient across the MIM. The passage of protons back into the matrix along 
the electrochemical gradient is utilized by ATP-synthase to produce ATP, thus coupling energy 






Figure 1. Mitochondrial electron transport, ATP production and protonophoric 
uncoupling. Left: The citric acid cycle produces NADH and FADH2, which are high energy 
electron sources for complexes I-IV (light blue). Cytochrome c (C) and coenzyme Q (Q) shuttle 
electrons between ETC complexes. In parallel, the ETC pumps protons into the intermembrane 
space to establish an electrochemical gradient across the MIM. Protons flow back across the 
MIM via ATP synthase (green) to catalyse the formation of ATP. Right: Protonophoric 
uncouplers (A-H) bypass ATP synthase and transport protons from the intermembrane space 
to the matrix. If sufficiently lipophilic, the conjugate anions (A-) are returned to the 
intermembrane space for further uncoupling cycles. Insert: chemical structures of 
representative protonophoric uncouplers.  
  
 6 
Mitochondrial uncouplers are compounds that induce proton leak across the MIM and 
into the matrix, leading to futile cycles of nutrient oxidation without ATP production. One of 
earliest known uncouplers, 2,4-dinitrophenol (2,4-DNP, Figure 1), was clinically used as a 
weight loss drug in the 1930s until it was withdrawn due to unacceptable toxicities. Despite 
safety concerns, there has been a resurgence of interest in uncouplers because of their potential 
uses in metabolic diseases such as obesity and non-insulin-dependent diabetes, 
neurodegenerative diseases and cancer.1  
Protonophoric mitochondrial uncouplers are lipophilic weak acids (pKa ~ 4-8) that 
shuttle protons across the MIM in a protein-independent cycle. The protonated uncoupler (HA 
in Figure 1) first diffuses across the MIM and carries a proton from the intermembrane space 
to the matrix.1, 2 Proton release in the alkaline matrix generates the protonophore anion (A- in 
Figure 1), and further uncoupling cycles can only occur if the anions passively diffuse across 
the MIM and return to the intermembrane space.2 The acidic groups in protonophores are 
therefore part of delocalised π-systems that spread negative charge over large surfaces and 
promote anion lipophilicity and protonophoric cycling (Figure 1).3 In contrast, fatty acids such 
as palmitic acid cannot complete the cycle because the anion, which has negative charge 
localized on the carboxylate group, is too polar to permeate the MIM. Instead, fatty acid-
mediated uncoupling proceeds by a protein-dependant mechanism in which the anion is 
actively transported across the MIM by transport proteins such as adenine nucleotide 
translocase (ANT).4, 5 
Synthetic anion transporters are small-molecule organic compounds that facilitate the 
transport of anionic species such as Cl- and HCO3- across lipid bilayers.6, 7 Non-channel 
forming anion transporters contain anion recognition motifs (e.g. urea, thiourea, and 
sulphonamide groups) that bind their guest anion through non-covalent interactions to form 
supramolecular complexes on one side of the membrane.8 Delocalisation of the anionic charge 
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within these assemblies allows them to diffuse across the bilayer and translocate the anion. 
Synthetic anion transporters have received significant research attention due to their potential 
therapeutic applications,9, 10 for example in treating cystic fibrosis11 and as anticancer agents 
where disruption of intracellular anion concentrations can induce cell death.12  
In this paper we reveal the mitochondrial actions of a fatty acid substituted with a urea-
based anion transporter motif at the molecular scale. These compounds (termed aryl-ureas) 
induce mitochondrial dysfunction in breast cancer cells,13 and here we demonstrate that they 
act as mitochondrial uncouplers. Protein-independent, protonophoric actions of the aryl-ureas 
is established using a new assay that utilises tethered lipid bilayers in conjunction with 
electrical impedance spectroscopy. The rate limiting step in the protonophoric cycle, 
translocation of the deprotonated uncoupler across the MIM, proceeds via self-assembly into 
dimeric and multimeric complexes formed by hydrogen bonding between the carboxylate and 
urea anion binding groups. Aryl-substitution with electron withdrawing and lipophilic groups 
promotes delocalisation of the carboxylate charge across the aryl urea system and provides 
membrane permeability to the complexes. By providing the flexibility to separate the acidic 
moiety from the conjugated π system, these findings open up new possibilities for the design 






Results and Discussion 
Compound library design and synthesis 
Aryl ureas capable of disrupting energy production in breast cancer cells possess strong 
electron withdrawing substituents (σtotal > 0.66) in the meta- and para- positions of the aryl 
ring.13, 14 In this study a series of aryl-ureas was prepared bearing electron withdrawing aryl-
substituents of varying polarity, determined from the hydrophobicity constants (πtotal, see Table 
1), to assess the influence of substituent lipophilicity on activity. The compounds were 
synthesised in 2 steps using N,N-carbonyldiimidazole (CDI) chemistry to form the substituted 
aryl urea moieties (see Scheme S1 in Supporting Information).     
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Table 1. Chemical structures, aromatic substituent constants and JC-1 IC50 concentrations  
  
Compound R σtotala πtotala JC-1 IC50 (µM) 
1 
 
0.66 1.56 4.5 ± 1.1 
2 
 
0.68 1.23 14 ± 1 
3 
 
0.71 -0.28 inactiveb 
4 
 
0.72 -1.63 inactiveb 
5 
 
0.78 -0.28 inactiveb 
6 
 
0.80 1.56 2.9 ± 1.1 
7 
 
0.84 -0.14 inactiveb 
8 
 
0.91 1.56 7.2 ± 1.2 
9 
 
0.96 0.55 6.4 ± 1.2 
10 
 
0.97 1.76 7.6 ± 1.2 
11 
 
0.98 1.94 6.0 ± 1.0 
12 
 

































1.21 0.60 7.6 ± 1.2 
aHammett substituent constants were taken from published values.15 σp was used for ortho 
substituents. bInactive: no change in the JC-1 red: green ratio when tested at 50 µM. 
 
 
Mitochondrial actions of aryl ureas 
We evaluated the capacity of the aryl-ureas to depolarize the MIM in MDA-MB-231 
cells using the JC-1 assay. JC-1 is a redox active dye that forms aggregates that fluoresce red 
in energized mitochondria with high membrane potential. Mitochondrial uncouplers dissipate 
the membrane potential so that JC-1 remains in its monomeric form and fluoresces green. We 
determined JC-1 IC50s for aryl-ureas as the concentrations required to shift the red:green 
fluorescence ratio by 50% (Table 1). The active analogues 1, 2, 6, 8, 9, 10, 11, and 13 shifted 
the JC-1 red:green fluorescence ratio with IC50s between 3-14 µM. These analogues also 
markedly impaired ATP production at concentrations above their JC-1 IC50 values (10 and 40 
μM, Figure 2a). In contrast, the ortho-substituted analogues 7 and 12 did not alter the JC-1 
red:green fluorescence ratio or modulate ATP production. These findings are consistent with 
our previous finding that only aryl-ureas with strongly electron-withdrawing groups in the 
meta- and para-positions promoted mitochondrial dysfunction.13, 14 
 Analogues 3, 4, and 5 were also inactive. These analogues possess the hydrophilic 
substituents (negative πtotal values), indicating that substituent lipophilicity is also critical to 
activity. This is further illustrated by comparison of 9 and 4. These compounds have similar 
electronic and steric properties, but differ markedly in lipophilicity. The more lipophilic 9 






Figure 2. Effects of aryl-ureas 1-13 of mitochondrial function in MDA-MB-231 cells. a) ATP 
formation by MDA-MB-231 cells after 24 hours treatments with 1-13. b) Oxygen consumption 
rates (OCR) in MDA-MB-231 cells after sequential addition of the ATP-synthase inhibitor 
oligomycin (1 µM; arrow a), protonophore FCCP (1 µM) or aryl-ureas (20 µM; arrow b), and 
then the ETC complex inhibitors rotenone/antimycin A (1 µM).  Data represents the mean ± 
SEM of 3 independent experiments. Different from DMSO treated control: (‡) P < 0.0001, (†) 
P < 0.001, (*) P < 0.05 
 
Impaired ATP production and mitochondrial membrane depolarization are consistent 
with uncoupling. To confirm that the active aryl ureas are uncouplers we used the Seahorse 
Mito Stress test, which measures cellular oxygen consumption rate (OCR) in the presence of 
the ATP synthase inhibitor oligomycin. Addition of uncouplers under these conditions 
increases OCR. When added to MDA-MB-231 cells treated with oligomycin all of the active 
aryl-ureas, as well as the known protonophore FCCP, increased OCR approximately 5-fold 
over control (Figure 2b; Figure S1 in Supporting Information). In contrast, the inactive 
analogues did not increase OCR (Figure 2b and Figure S1). Taken together, these data show 
that aryl-ureas with lipophilic and electron withdrawing substituents in the meta and para 
positions are mitochondrial uncouplers that depolarise the MIM and impair ATP production. 
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Mechanism of uncoupling 
We next sought to define the mechanism of aryl-urea mediated uncoupling. The 
recoupling agent 6-ketocholesterol (6-KCH) is commonly used in cell-based assays to 
distinguish protein-independent uncouplers from those that rely on transport proteins 
embedded in the MIM to complete the uncoupling cycle.16 6-KCH is suggested to incorporate 
into the MIM and selectively inhibit anion permeation, which is the rate limiting step in 
protonophoric cycling. In JC-1 assays, pre- or co-treatment of MDA-MB-231 cells with 6-
KCH failed to prevent 6 mediated mitochondrial depolarisation (data not shown). These 
findings however do not rule out a protonophoric mechanism for 6 because 6-KCH mediated-
recoupling only affects protonophores of certain structural classes.17 Indeed, unambiguous 
identification of a protein-dependant mechanism involves complex and time-consuming cell-
based assays.18 We therefore sought to develop a new assay to rapidly and unambiguously 
identify compounds with protonophoric activity.  
Lipid bilayers tethered to a thin film gold electrode, when used in conjunction with 
electrical impedance spectroscopy, permit a measure of ionic membrane conductance over 
prolonged periods.19 We hypothesized that this system could be used to identify protonophores 
because their addition to the lipid membrane should increase conductance by transporting 
protons across the bilayer, while protein-dependant uncouplers should have no effect. 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) lipid bilayers were used in the assays because 
phosphatidylcholine is the major lipid component of the MIM.20  Consistent with our 
hypothesis, addition of active aryl-ureas 1 and 6, as well as the known protonophore FCCP, 
increased bilayer conductance compared to a control (Figure 3a), consistent with increased 
ionic transport across the bilayer. In contrast, the inactive aryl urea 7 and the protein-dependant 
uncoupler palmitic acid failed to effect conductance. To confirm that changes in conductance 
 13 
were due to proton transport, and not to other metal cations, experiments were conducted over 
an expanded pH range on a background of a constant concentration of 100 mM NaCl (Figure 
3b). At lower pH values (3-5) higher proton concentrations increased membrane conductance 
in the presence of active aryl-ureas 1 and 6, but not inactive analogue 7. Decreased membrane 
conductance at pH 6 has been previously observed in studies using this model lipid bilayer 
platform, has been attributed to tighter packing of the lipids in the bilayer due to increased 
hydrogen bonding at the lipid interface.19, 21 Thus the changes in membrane conductance 
observed over the pH range are consistent with the ability of 1 and 6 to transport protons across 
the lipid bilayer. To the best of our knowledge, this is the first example of tethered lipid bilayers 
in conjunction with electrical impedance spectroscopy to identify protonophoric agents capable 
of directly modulating membrane proton transport. 
 
Figure 3. Aryl-ureas and the protonophore FCCP modulate proton conductance in tethered 
lipid bilayer membranes.  a) Addition of active aryl ureas 1 and 6 (10 µM) and FCCP (0.5 µM) 
increased conductance across a DOPC lipid bilayer tethered to a gold electrode, as measured 
by electrical impedance spectroscopy. The inactive aryl urea 7 (10 µM) and protein-dependant 
uncoupler palmitic acid failed to increase bilayer conductance. Data normalised to baseline 
control. b) Sequential reduction of membrane pH leads to an increase in relative membrane 
conductivity for active aryl ureas 1 and 6 (10 µM). For the inactive aryl urea 7 (10 µM) there 
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was no relative conductance increase. Data normalised to conductance of aryl-urea treated 
membranes at pH = 7. Data represents the mean ± SEM of 3 independent experiments. 
 
To further characterise the uncoupling mechanism, we sought to identify the acidic 
functional groups in the aryl-ureas that facilitate protonophoric cycling. The carboxylic acid 
groups lack connection to a delocalised π system and would not be expected to generate a 
MIM-permeable anion after deprotonation. The urea proton adjacent to the aryl ring are part of 
the delocalised aryl urea system and are potentially acidic due to the strongly electron 
withdrawing aryl substituents that are required for activity. However, high-level ab initio 
calculations indicate that pKa values for these protons (~11–14, see Table S1 in Supporting 
Information) are too high to dissociate in the matrix. To evaluate the potential roles of the 
carboxylate and urea moieties in uncoupling, we prepared esterified (6-Me) and N,N-
dimethylated urea (6-NNMe) analogues of 6 (Figure 4a and Supporting Information) and 
assessed their protonophoric activity.  
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Figure 4. Methyl ester (6-Me) and NN-dimethylated (6-NNMe) analogues of aryl-urea 6 lack 
uncoupling and protonophoric activity. a) Chemical structure of 6 analogues. b) OCR in MDA-
MB-231 cells treated sequentially with the ATP-synthase inhibitor oligomycin (1 µM), test 
compound (20 µM), and then ETC complex inhibitors rotenone/antimycin A (1 µM), as 
indicated.  c) Effects of 6, 6-Me and 6-NNMe (10 µM) on the conductance of DOPC tethered 
lipid bilayers measured by impedance spectroscopy. Data represents the mean ± SEM of 3 
independent experiments. 
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As shown in Figure 4b, removal of either the carboxylic acid group (6-Me, 20 µM) or 
the urea NHs (6-NNMe, 20 µM) produced analogues that were devoid of uncoupling activity 
in Seahorse Mito Stress tests. Similarly, neither compound (10 µM) increased proton 
conductance in the tethered lipid bilayer model (Figure 4c).  
  The inactivity of 6-Me and 6-NNMe indicate that both functional groups are essential 
for uncoupling activity and that interaction of these groups occurs during the protonophoric 
cycle. This led us to postulate that the urea group functions as a synthetic anion transporter to 
facilitate diffusion of a deprotonated species across the MIM. Indeed, urea derivatives are 
known anion receptors that form strong interactions with carboxylate groups comprised of two 
parallel NH···O hydrogen bonds.22 Through-bond propagation of electron density delocalizes 
the carboxylate negative charge across the aryl-urea system, and the resulting complexes are 
stable in non-polar solvents (reflecting the membrane environment).23, 24 The structure-activity 
relationship of the aryl-ureas is also consistent with that of anion transporters, where inclusion 
of electron withdrawing25 and lipophilic26 aryl substituents promotes transporter activity.9, 27 
Further, it has been shown that thioureas act as fatty acid anion membrane transporters by a 
mechanism that relies on the formation of hydrogen-bonded membrane-permeable 
complexes.28 To understand how urea/carboxylate interaction could facilitate aryl urea-
mediated uncoupling the formation and nature of the membrane permeable anionic species 
formed by the aryl ureas was evaluated using Density Functional Theory (DFT). 
 Binding free energies were calculated for the complexation of model (tail-truncated) 
aryl ureas with propanoate at the M06-2X/6-31+G(d) level of theory (see Computational 
Methodology).29  Complexation in both water and in n-pentadecane (chosen to mimic the low 
dielectric environment of a lipid membrane) was investigated using the SMD continuum 
solvation model.30 In water, binding free energies ranged from ~-1 to 8 kJ/mol over the full 
compound set (Table S1), indicating that carboxylate complexation by aryl ureas is thermo-
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neutral to slightly unfavourable in an aqueous environment. In contrast, binding free energies 
in n-pentadecane were highly favourable: ranging from -117 to -95 kJ/mol for the active 
analogues and -99 to -79 kJ/mol for the inactive analogues (Table S1). The highly favourable 
complexation of carboxylates by aryl ureas in non-aqueous solvent, combined with the thermo-
neutral to slightly unfavourable binding in water, indicates that the thermodynamic stability of 
these complexes is highly dependent on their local dielectric environment. Specifically, these 
complexes would be stable to dissociation within the lipid membrane but not at the water 
interface. This mechanism is consistent with the reversible transport of carboxylate moieties 
by aryl ureas required for uncoupling.  
Aryl-ureas containing electron-withdrawing substituents ortho to the urea moiety did 
not disrupt the mitochondrial membrane potential or impair ATP production (Table 1, Figure 
2). To rationalize this, the carboxylate binding affinity and electronic structure of the inactive 
12 were compared with the highly active 6. Despite the favourable aryl substitution pattern and 
lipophilicity (σtotal and πtotal values of 1.0 and 2.30 respectively) for 12, compared to 6 (0.80 
and 1.56 respectively), the complexation free energy of 12 and propanoate in n-pentadecane 
was low compared to that of 6 (-79 kJ/mol vs -95 kJ/mol respectively). This is due to an 
unfavourable steric interaction between the carboxylate moiety and the ortho substituent of 12. 
Additionally, ortho substitution forces the urea group out of plane with the aryl π-system, which 
hinders charge delocalization in the respective complex. Figure 5 shows the HOMOs of 6 and 
12 complexed with propanoate (Figure 5a, b respectively). In the case of the 12-propanoate 
complex greater HOMO density is localized on the propanoate moiety and the distorted π-
system prevents constructive HOMO overlap between the urea and aryl moieties (Figure 5b). 





Figure 5: HOMOs of aryl urea model compounds, a) 6 and b) 12 in complex with propanoate. 
Calculations were conducted at the M06-2X/6-31+G(d) level of theory. 
Lipophilicity is a major determinant of trans-bilayer ion transport activity and is closely 
linked to charge delocalization of the ionic species. To assess the lipophilicity of the aryl-urea 
analogues, free energies for transfer of propanoate-complexed aryl-ureas from water to n-
pentadecane were calculated (∆GSolvComplex(W-P), see Computational Methodology).  
Impaired anion delocalization results in high free energies of solvent transfer for 12 relative to 
6 (99 kJ/mol and 80 kJ/mol respectively, Table S2) and consequently much lower expected 
membrane permeability of the anionic complex.  In contrast, the free energy of solvent transfer 
for isolated 12 (∆GSolvMonomer(W-P), see Computational Methodology) is more favourable than 
6 (5 vs 7 kJ/mol respectively, Table S2). Thus, the unfavourable HOMO localization and π-
system orientation of carboxylate complexed aryl-ureas can account for the lack of activity of 
ortho-substituted analogues.  
Interaction of the urea and carboxylate moieties to form anionic complexes was 
demonstrated with DFT calculations, however whether this interaction occurs via intra- or 
inter-molecular complexation was unclear.  To clarify this, we sought crystal structures of 6 in 
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it’s protonated and deprotonated carboxylate from (6-D). 6-D failed to crystallise, however we 
obtained single crystals of 6 and 6-DMF solvate. In both crystal structures (Figure 6a, b), 6 
formed head-to-tail dimers stabilised by multiple hydrogen bonds between urea NH donors and 
carboxylic acid C=O acceptors. The dimerisation observed in the solid-state indicates possible 
intermolecular association of 6 within the low polarity environment of lipid bilayers 
 
 
Figure 6. Single crystal structure of 6 (a, CCDC 1998411) and 6-DMF solvate (b, CCDC 
1998415) with hydrogen bonds represented by red dashed lines. 
 
To further investigate the possible formation of membrane permeable dimers in a 
bilayer environment, we conducted molecular dynamics (MD) simulations of the active 
analogue 6 interacting with a DOPC bilayer in relevant protonation states (see Computational 
Methodology). 6 in its deprotonated carboxylate form (6-D) and the neutral carboxylic acid 
form (6) readily integrated into a GROMOS-54A7 DOPC bilayer30, 31 in microsecond timescale 
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MD simulations. The carboxylate tail of 6-D was excluded from the bilayer interior and was 
restricted to the upper leaflet (Figure S2a, b), while the neutral 6 readily diffused between the 
two leaflets over the timescale of the simulation (Figure S2c, d). The exclusion of the 
carboxylate tail of 6-D from the bilayer interior is consistent with the protein-dependent 
uncoupling mechanisms of isolated fatty acids, where anion transport is transporter mediated.  
Intra-molecular complexation of the urea and carboxylate moieties was not observed 
over the simulation timescale. However, similar to the aggregation of 6 observed in crystal 
structures (Figure 6), both 6-D and 6 formed head-to-tail dimeric or multimeric structures in 
the DOPC bilayer environment (Figure 7a, b).  Dimers and multimers occurred both in 
simulations containing a single species (e.g only 6-D or only 6) and in simulations containing 
both 6-D and 6 (see Computational Methodology). Despite the tendency of 6-D to aggregate 
with 6 or other 6-D molecules in the bilayer, no inter-leaflet translocation of the resultant 
carboxylate-containing complexes was observed over the simulation timescale. However, it 
should be noted that there was no charge gradient across the bilayer in our MD simulations; in 
mitochondria anion translocation across the MIM is driven by the electrochemical gradient. 
The higher inter-leaflet permeability of 6, and the formation of head-to-tail 6-D - 6 complexes 
suggests that co-transport of the carboxylate moieties with protonated aryl ureas is likely to be 
preferred over co-transport of two complexed carboxylates. In support of this, the translocation 
of anionic species complexed with their conjugate acids has previously been proposed for other 
uncouplers.16, 32   
To confirm the identity of the membrane permeable species we performed 
concentration-dependent 1H NMR studies of 6 in CDCl3 after deprotonation by 
tetrabutylammonium hydroxide (TBAOH). By increasing the concentration of 6-TBAOH from 
50 μM to 5.0 mM, we observed dramatic downfield shifts in the aromatic CH peaks of 6-
TBAOH (Figure S3), which is consistent with the inter-molecular complexation in CDCl3. The 
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translational diffusion coefficients of 6-TBAOH at 50 μM and 5.0 mM determined by 
diffusional NMR do not show a significant difference within experimental errors (Table S3), 
which rules out the formation of large aggregates. The concentration-dependent chemical shifts 
could be fitted to a monomer-dimer aggregation model (Figure S4), giving a dimerisation 
equilibrium constant of 5.9 × 103 M-1 for 6-TBAOH in CDCl3. To further support dimer 
formation we also measured the concentration dependant effects of 6 on bilayer conductance. 
Uncouplers that form membrane permeable dimers display a quadratic relationship between 
bilayer conductance and uncoupler concentration,32 and in tethered bilayers treated with 6 
conductance was proportional to the square of the concentration of 6 (Figure S5). Together 
with the DFT calculations and MD, these studies show that aryl urea mediated uncoupling 
proceeds via self-assembly into lipophilic dimers as summarised in Figure 7c. 
  
 
Figure 7. Self-assembly of aryl-ureas into membrane permeable dimeric complexes. Panels a) 
and b) Dimeric and multimeric assemblies of 6-D and 6 formed in a DOPC bilayer. 6-D and 6 
are shown in green and blue respectively, while the phosphorous atoms of the phospholipid 
head groups are shown as orange spheres. Lipid acyl chains and headgroup structures are 
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omitted for clarity and water is shown in light blue. Partial dimerization of 6-D is shown in (a), 
while formation of a head-to-tail 6-D-(6)2 trimer is shown in (b). c) Proposed mechanism of 
uncoupling via dimer formation.  
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Conclusions 
In this paper we report the first example of a protonophoric mitochondrial uncoupler in which 
the acidic group and delocalised π system are separated by an alkyl chain. Uncoupling activity 
was established in cell-based assays and we developed a simple method using tethered lipid 
bilayers in conjunction with electrical impedence spectroscopy to show that the aryl-ureas are 
protein independant protonophores. The rate-limting step in the protonophoric cycle, diffusion 
of the deportonated uncoupler across the MIM, proceeds via self-assemly of the aryl-ureas into 
dimeric complexes. Intermolecular hydrogen bonds between the carboxylate and anion binding 
urea group delocalizes the negative charge to promote membrane permeability, and overall 
complex lipophilicity is enhanced by electron withdrawing and lipophilic meta- and para-aryl 
substituents. The aryl-ureas studied herein represent a new type of mitochondrial uncoupler 
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